ALMOND – Technology for Alzheimer’s Monitoring and Diagnosis
There is a strong need for doctors and researchers to identify behavior patterns and symptoms associated with Alzheimer’s disease and make objective treatment decisions. The pharmaceutical industry is looking for technical monitoring solutions to objectively measure the efficacy of new drug developments. The ALMOND technology addresses this need, providing clinicians and industry with remote and continuous monitoring capabilities to objectively assess treatment effects. The ALMOND technology will enable precision treatment strategies that are optimised for individual Alzheimer’s patients, improving their quality of life and reducing caregiver’s burden.